Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

Davies, C (author)

Pan, HC (author)

Godwin, J (author)

show more...

Gray, R (author)

Arriagada, R (author)

Karolinska Institutet

Raina, V (author)

Abraham, M (author)

Alencar, VHM (author)

Badran, A (author)

Bonfill, X (author)

Bradbury, J (author)

Clarke, M (author)

Collins, R (author)

Davis, SR (author)

Delmestri, A (author)

Forbes, JF (author)

Haddad, P (author)

Hou, MF (author)

Inbar, M (author)

Khaled, H (author)

Kielanowska, J (author)

Kwan, WH (author)

Mathew, BS (author)

Mittra, I (author)

Muller, B (author)

Nicolucci, A (author)

Peralta, O (author)

Pernas, F (author)

Petruzelka, L (author)

Pienkowski, T (author)

Radhika, R (author)

Rajan, B (author)

Rubach, MT (author)

Tort, S (author)

Urrutia, G (author)

Valentini, M (author)

Wang, YC (author)

Peto, R (author)

show less...

 (creator_code:org_t)

2013

2013

English.

In: Lancet (London, England). - 1474-547X. ; 381:9869, s. 805-816

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)